Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as
therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin
disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC
Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech blog
Developer Forum Europe PMC plus Search life-sciences literature (Over 40 million articles,
preprints and more) Search Advanced search Feedback This website requires cookies, and the …